Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells

Nutrition and Cancer

Volumn 49, Issue 1, 2004, Pages 100-108

  Song, Hyun Ju ^a   Sneddon, Alan A ^a   Barker, Pamela A ^b   Bestwick, Charles ^a   Choe, Sun Nam ^c   McClinton, Sam ^b   Grant, Ian ^d   Rotondo, Dino ^e   Heys, Steven D ^b   Wahle, Klaus W J ^d  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c Kunsan National University   (South Korea)

^d ROBERT GORDON UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

10 LINOLEIC ACID; 11 LINOLEIC ACID; 12 LINOLEIC ACID; 9 LINOLEIC ACID; CONJUGATED LINOLEIC ACID; CYTOPLASM PROTEIN; ISOENZYME; MEMBRANE PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C IOTA; PROTEIN KINASE C MU; PROTEIN KINASE C ZETA; UNCLASSIFIED DRUG;

ANIMAL FOOD; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; CYTOPLASM; DIET; ENZYME ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIFESTYLE; MODULATION; PROSTATE CANCER; PROSTATE CANCER CELL; PROTEIN CONTENT; SUPPLEMENTATION; WESTERN BLOTTING;

ANIMALIA;

EID: 4644312970     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4901_14     Document Type: Article

References (36)

1. Pariza M, Park Y, and Cook ME: The biologically active isomers of conjugated linoleic acid. Prog Lipid Res 40, 283-298, 2001.
2. Baumann DE and Griinari JM: Regulation and nutritional manipulation of milk fat: low-fat milk syndrome. Livestock Prod Sci 70(1-2), 15-29, 2001.
3. Griinari JM, Cori BA, Lacey SH, Chouinard PY, Nurmela KVV, et al.: Conjugated linoleic acid is synthesized endogenously in lactating dairy cows by Delta(9)-desaturase. J Nutr 130, 2285-2291, 2000.
4. Saebo A: Commercial synthesis of conjugated linoleate. In Advances in Conjugated Linoleic Acid Research 2, Sebedio JL, Christie WW, and Adlof R (eds.). Champaign, IL: AOCS Press, 2003, pp 71-81.
5. Wahle KWJ: Inhibition of delta-9 desaturase activity in cow mammary microsomes by trans vacennic acid, 1981. Unpublished observations. Available from Wahle KWJ, Robert Gordon University, Aberdeen, Scotland.
6. Ip C, Dong Y, Thompson HJ, Bauman DE, and Ip M.M: Control of rat mammary epithelium proliferation by conjugated linoleic acid. Nutr Cancer 39, 233-238, 2001.
7. Palombo JD, Ganguly A, Bistrian BR, and Menard M.P: The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells. Cancer Let. 177, 163-172, 2002.
8. , Majumder B, Wahle KWJ, Moir S, Schofield A, Choe S-N, et al.: Conjugated linoleic acids (CLAs) regulate the expression of key apoptotic genes in human breast cancer cells. FASEB J 16(9), U85-U105, 2002.
9. Cesano A, Visonneau S, Scimeca JA, Kritchevsky D, and Santoli D: Opposite effects of linoleic acid and conjugated linoleic acid on human prostatic cancer in SCID mice. Anticancer Res 18(3A), 1429-1434, 1998.
10. Deacon EM, Pongracz J, Griffiths G, and Lord J.M: Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. Mol Pathol 50, 124-131, 1997.
11. Hug H and Sarre TF: Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 291, 329-343, 1993.
12. Lamm ML, Long DD, Goodwin SM, and Lee C: Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3. Endocrinology 138(11), 4657-64, 1997.
13. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, et al.: Persistent membrane translocation of protein kinase C alpha during 12-0- tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 7(4), 419-428, 1996.
14. Rusnak J.M.and Lazo JS: Downregulation of protein kinase C suppresses induction of apoptosis in human prostatic carcinoma cells. Exp Cell Res 224, 189-199, 1996.
15. Konno S, Hsieh T C, Wu J.M, Chen Y, Chiao JW, et al.: Growth control of human prostatic cancer cells by the phorbol ester TPA: possible involvement of protein kinases. Anticancer Res 16, 1843-1849, 1996.
16. Hrzenjak M and Shain SA: Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways. Recepr Signal Transduct 7, 207-219, 1997.
17. Hellberg CB, Burden-Gulley SM, Pietz GE, and Brady-Kalnay SM: Expression of the receptor protein-tyrosine phosphatase, PTPmu, restores E-cadherin-dependent adhesion in human prostate carcinoma cells. J Biol Chem 277(13), 11165-11173, 2002.
18. Kruger EA, Blagosklonny MV, Dixon SC, and Figg WD: UCN-01, a protein kinase C inhibitor, inhibits endothelial cell proliferation and angiogenic hypoxic response. Invasion Metastasis 18, 209-218, 2000.
19. Krongrad A and Bai G: c-fos Promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells. Cancer Res 54(23), 6073-6077, 1994.
20. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, et al.: Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279(3), L429-438, 2000.
21. Ip MM, Masso-Welch PA, Shoemaker SF, Shea-Eaton WK, and Ip C: Conjugated linoleic acid inhibits proliferation and induces apoptosis of normal rat mammary epithelial cells in primary culture. Exp Cell Res 250, 22-34, 1999.
22. Park Y, Allen KG, and Shultz TD: Modulation of MCF-7 breast cancer cell signal transduction by linoleic acid and conjugated linoleic acid in culture. Anticancer Res 20(2A), 669-676, 2000.
23. Newton AC, and Johnson JE: Protein kinase C: a paradigm for regulation of protein function by two membrane-targeting modules. Biochim Biophys Acta 1376(2), 155-172, 1998.
24. Pandian SS, Sneddon AA, Bestwick CS, McClinton S, Grant I, et al.: Fatty acid regulation of protein kinase C isoforms in prostate cancer cells. Biochem Biophys Res Commun 283, 806-812, 2001.
25. Barker PA, Duncan L, McClinton S, Wahle KWJ, Heys SD, et al.: Conjugated linoleic acid (CLA) inhibits cancer cell growth differentially in androgen-sensitive and androgen-independent human prostate cancer cells [Abstract]. Br Assoc Surg Oncol London, 2002.
26. Garcia-Bermejo ML, Leskow FC, Fujii T, Wang Q, Blumberg PM, et al.: Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha. J Biol Chem 277(1), 645-655, 2002.
27. Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T, et al.: Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J Clin Invest 109(6), 827-836, 2002.
28. Fujii T, Garcia-Bermejo ML, Bernabo JL, Caamano J, Ohba M, et al.: Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. J Biol Chem 275(11), 7574-7582, 2000.
29. Pongracz J, Webb P, Wang K, Deacon E, Lunn OJ, et al.: Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta. J Biol Chem 274(52), 37329-37334, 1999.
30. Cerda SR, Bissonnette M, Scaglione-Sewell B, Lyons MR, Khare S, et al.: PKC-delta inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apoptosis in CaCo-2 cells. Gastroenterology 120(7), 1700-1712, 2001.
31. Ip C, Ip MM, Loftus T, Shoemaker S, and Shea-Eaton W: Induction of apoptosis by conjugated linoleic acid in cultured mammary tumor cells and premalignant lesions of the rat mammary gland. Cancer Epidemiol Biomarkers Prevent 9, 689-696, 2000.
32. Ip C, Dong Y, Ip MM, Banni S, Carta G, et al.: Conjugated linoleic acid isomers and mammary cancer prevention. Nutr Cancer 43(1), 52-58, 2002.
33. Ways DK, Kukoly CA, de Vente J, Hooker JL, Bryant WO, et al.: MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J Clin Invest 95, 1906-1915, 1995.
34. Brandlin I, Hubner S, Eiseler T, Martinez-Moya MA, Hausser A, et al.: Protein kinase C (PKC)eta-mediated PKC mu activation modulates ERK and JNK signal pathways. J Biol Chem 277(8), 6490-6496, 2002.
35. Endo K, Oki E, Biedermann V, Kojima H, Yoshida K, et al.: Proteolytic cleavage and activation of protein kinase C [micro] by caspase-3 in the apoptotic response of cells to 1-beta -D-arabinofuranosylcytosine and other genotoxic agents. J Biol Chem 275(24), 18476-18481, 2000.
36. Comford P, Evans J, Dodson A, Parsons K, Woolfenden A, et al.: Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. Am J Pathol 154(1), 137-144, 1999.